Oxford Nanopore TechnologiesLSE:ONT +1.33%74 Current Ratio is 3.56 as of Dec. 2025, which is 26% below its 10-year median of 4.84. GuruFocus rates LSE:ONT with a GF Score™ of 74/100 and a GF Value™ of £1.87 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,417 Biotechnology companies, Oxford Nanopore Technologies ranks worse than 53.35% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Oxford Nanopore Technologies's current ratio for the quarter that ended in Dec. 2025 was 3.56.
Oxford Nanopore Technologies has a current ratio of 3.56. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Oxford Nanopore Technologies's Current Ratio or its related term are showing as below:
LSE:ONT'
s Current Ratio Range Over the Past 10 Years
Min: 2.81 Med: 4.84 Max: 7.15
Current: 3.56
During the past 8 years, Oxford Nanopore Technologies's highest Current Ratio was 7.15. The lowest was 2.81. And the median was 4.84.
LSE:ONT's Current Ratio is ranked worse than 53.35% of 1417
companies
in the Biotechnology industry
Industry Median: 3.89
vs LSE:ONT: 3.56
Oxford Nanopore Technologies (LSE:ONT) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Oxford Nanopore Technologies Current Ratio Related Terms
Oxford Nanopore Technologies Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:ONT vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, Oxford Nanopore Technologies's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Nanopore Technologies Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Current Ratio distribution charts can be found below:
* The bar in red indicates where Oxford Nanopore Technologies's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford Nanopore Technologies (LSE:ONT) has a Current Ratio of 3.56 as of Dec. 2025. This is 26% below median its historical median of 4.84. Over the past decade, Oxford Nanopore Technologies' Current Ratio has ranged from 2.81 to 7.15. According to the industry distribution chart, Oxford Nanopore Technologies ranks #756 out of 1417 companies in the Biotechnology industry, placing it in the top 53.4%.
Is Oxford Nanopore Technologies' Current Ratio too high?
Oxford Nanopore Technologies' current Current Ratio of 3.56 is 26% below median its 10-year median of 4.84. Over the past 10 years, this metric has ranged from a low of 2.81 to a high of 7.15. The Biotechnology industry median Current Ratio is 3.89. Oxford Nanopore Technologies' value of 3.56 is 8.5% below this industry median. Based on the distribution chart, Oxford Nanopore Technologies ranks #756 out of 1417 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oxford Nanopore Technologies has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #756 out of 1417 companies for Current Ratio. This places Oxford Nanopore Technologies in the lower half of its industry. The industry median Current Ratio is 3.89. Oxford Nanopore Technologies' value of 3.56 is 8.5% below this benchmark. Historically, Oxford Nanopore Technologies' own Current Ratio has ranged from 2.81 to 7.15 over the past decade. While the company's 10-year median is 4.84 vs. the industry median of 3.89, Oxford Nanopore Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford Nanopore Technologies's current Current Ratio of 3.56 is 8.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current Current Ratio is 3.56, which is 26% below median its own 10-year median of 4.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (LSE:ONT) is currently considered Significantly Undervalued. The stock's GF Value™ is £1.87, compared to a current price of £1.15 — trading 38.7% below its estimated fair value. The current Current Ratio is 3.56, which is 26% below median its 10-year median of 4.84 and 8.5% below the Biotechnology industry median of 3.89. Oxford Nanopore Technologies' overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Oxford Nanopore Technologies (LSE:ONT), the current Current Ratio is 3.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxford Nanopore Technologies (LSE:ONT) Overvalued in 2026?
Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued.
The current stock price of £1.15 is trading 38.7% below its estimated GF Value™ of £1.87.
GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.
Key valuation signals for LSE:ONT:
Current Ratio: 3.56 (26% below median its 10-year median of 4.84)
GF Value™: £1.87 vs. price of £1.15 (38.7% below fair value)
Industry Position: 8.5% below the Biotechnology median (#756 of 1417)
No single metric tells the full story. See the LSE:ONT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
74GF Score
Get the complete analysis for LSE:ONT
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:ONT has been successfully added to your 
